Previous close | 94.73 |
Open | 94.50 |
Bid | 95.63 x 90000 |
Ask | 95.93 x 90000 |
Day's range | 94.41 - 95.36 |
52-week range | 85.41 - 111.18 |
Volume | |
Avg. volume | 175 |
Market cap | 166.118B |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | 32.32 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.03 (2.15%) |
Ex-dividend date | 12 Apr 2024 |
1y target est | N/A |
We recently compiled the list of 25 Best Dividend Aristocrats Stocks According to Analysts. Since Abbott Laboratories (NYSE:ABT) ranks higher on our list, we have analyzed the stock in detail. The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm. Between these two, dividend growth is currently […]
The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
In the closing of the recent trading day, Abbott (ABT) stood at $103.23, denoting a -0.19% change from the preceding trading day.